Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000008

CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $122.25 ($611,273)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-06 Sale : show line 1 in the form 10b5-1 −3,124 $121.67 $380,097 44,057 D
2026-07-06 Sale : show line 2 in the form 10b5-1 −1,048 $122.43 $128,307 43,009 D
2026-07-06 Sale : show line 3 in the form 10b5-1 −528 $123.84 $65,388 42,481 D
2026-07-06 Sale : show line 4 in the form 10b5-1 −300 $124.94 $37,482 42,181 D
Open-market sales · 5,000 sh · avg $122.25 · $611,273
Loading xslF345X06/form4-07082026_090727.xml…